Class III — Low Risk

Low risk — use of or exposure to this product is not likely to cause adverse health consequences.

is a qualitative indirect enzyme immunoassay enzyme-linked immunosorbent assay (ELISA) Recalled by Euro Diagnostica AB Due to Incorrectly labeled Manufactured by DiaSorin, The correct term...

Date: October 21, 2016
Company: Euro Diagnostica AB
Status: Terminated
Source: FDA (Device)

What You Should Do

Stop using this product immediately. Do not consume, use, or distribute it.

Return the product to the place of purchase for a full refund. If you have questions, contact Euro Diagnostica AB directly.

Affected Products

is a qualitative indirect enzyme immunoassay enzyme-linked immunosorbent assay (ELISA) for the detection, in human serum or plasma, of antibodies specific for the Scl-70 antigen. The test is intended to as an aid to the diagnosis of scleroderma and is not definitive in isolation. Autoantibody levels represent one parameter in a multi-criterion diagnostic process.

Quantity: 4

Why Was This Recalled?

Incorrectly labeled Manufactured by DiaSorin, The correct term should be Distributed by DiaSorin.

Where Was This Sold?

This product was distributed to 1 state: MN

Affected (1 state)Not affected

About Euro Diagnostica AB

Euro Diagnostica AB has 8 total recalls tracked by RecallDetector.

Related Recalls

Data sourced from the FDA (Device). Last updated March 26, 2026. View original report